Kevin Robert Lind

Chief Financial Officer, Arena Pharmaceuticals.

Companies

Apnimed, Inc.Board member Jul 30, 2026 to now¹
Apnimed, Inc.Chief executive officer Jul 30, 2026 to now¹
Avalo Therapeutics, Inc.Board member Oct 2, 2025 to now²
Longboard Pharmaceuticals, Inc.Board member Mar 11, 2021 to Dec 2, 2024³
Longboard Pharmaceuticals, Inc.Chief executive officer Mar 11, 2021 to Dec 2, 2024³
Longboard Pharmaceuticals, Inc.President Mar 11, 2021 to Dec 2, 2024³
Arena PharmaceuticalsChief financial officer Jun 15, 2016 to Mar 3, 2020⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 2, 2024U 363,740 shares at $60.00 of Longboard Pharmaceuticals, Inc.⁵
Nov 13, 2024Gift 80,000 shares of Longboard Pharmaceuticals, Inc.⁶
Nov 13, 2024Exercised options 12,808 shares at $3.12 of Longboard Pharmaceuticals, Inc.⁶
Aug 12, 2024Exercised options 2,217 shares at $4.20 of Longboard Pharmaceuticals, Inc.⁷
Aug 12, 2024Exercised options 80,265 shares at $3.12 of Longboard Pharmaceuticals, Inc.⁷

The numbers on this page point here. Each one links to the record it came from.